Prosecution Insights
Last updated: October 04, 2026

Owen Mumford Ltd.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Owen Mumford Ltd. is prosecuting a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently contains 1 pending office action. This single action is handled by 1 distinct examiner and is located within 1 distinct art unit, representing a concentrated technical and administrative focus for the company's active US applications in this sector.

The busiest examiner for the portfolio is SCHMIDT, EMILY LOUISE, who is responsible for 1 busiest examiner pending action. Since there is only 1 pending office action in total, SCHMIDT, EMILY LOUISE manages the entire active workload for the company. This indicates that the current prosecution outcomes for Owen Mumford Ltd. in the Medical Devices & Mechanical Engineering field are dependent on the specific examination of this 1 pending matter.

Practitioners should focus their efforts on the 1 distinct examiner and the procedural expectations of the 1 distinct art unit. With no other pending actions or examiners involved, there is no broader portfolio data to suggest a varied prosecution strategy. The resolution of the 1 pending office action by SCHMIDT, EMILY LOUISE will be the defining event for the portfolio's current status.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SCHMIDT, EMILY LOUISE 1 58.4% +36.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18707110 SYRINGE IDENTIFICATION SCHMIDT, EMILY LOUISE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18707110 SYRINGE IDENTIFICATION SCHMIDT, EMILY LOUISE —

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18707110 SYRINGE IDENTIFICATION SCHMIDT, EMILY LOUISE 3783 §102§103§112 Non-Final OA — Pending May 02, 2024

Managing Owen Mumford Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month